The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
PAK-104P ID: ALA2074650
PubChem CID: 21226959
Product Number: P612607, Order Now?
Max Phase: Preclinical
Molecular Formula: C38H43N4O7P
Molecular Weight: 698.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(C)c(P2(=O)O[C@H](C)C[C@@H](C)O2)c(-c2cccc([N+](=O)[O-])c2)c1C(=O)OCCN1CCN(C(c2ccccc2)c2ccccc2)CC1
Standard InChI: InChI=1S/C38H43N4O7P/c1-26-24-27(2)49-50(46,48-26)37-29(4)39-28(3)34(35(37)32-16-11-17-33(25-32)42(44)45)38(43)47-23-22-40-18-20-41(21-19-40)36(30-12-7-5-8-13-30)31-14-9-6-10-15-31/h5-17,25-27,36H,18-24H2,1-4H3/t26-,27-/m1/s1
Standard InChI Key: PFKHLXIJSNUZDT-KAYWLYCHSA-N
Molfile:
RDKit 2D
50 55 0 0 0 0 0 0 0 0999 V2000
3.1821 0.0295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4676 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4676 -1.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1821 -1.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8966 -1.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8966 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1821 -2.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4676 -2.8580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4676 -3.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1821 -4.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8966 -3.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8966 -2.8580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7532 -1.6205 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
1.0387 -1.2081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3242 -1.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3242 -2.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0387 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7532 -2.4455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6111 -1.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3256 -1.2080 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0401 -1.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6111 -2.4455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7545 -1.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4690 -1.6205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4690 -2.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1835 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8980 -2.4456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8980 -1.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1835 -1.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6124 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3269 -2.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6124 -3.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8979 -4.0956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8979 -4.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6124 -5.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3269 -4.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3269 -4.0956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0414 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7559 -2.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7559 -1.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0414 -1.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3269 -1.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7532 -0.7955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0387 -3.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3903 -1.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6111 -4.0955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3256 -3.6830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6111 -4.9205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7532 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6111 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
4 7 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
3 13 1 0
13 14 1 0
18 13 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
5 19 1 0
19 20 1 0
20 21 1 0
19 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
29 24 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
27 30 1 0
30 31 1 0
30 32 1 0
32 33 1 0
32 37 2 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
31 38 1 0
31 42 2 0
38 39 2 0
39 40 1 0
40 41 2 0
41 42 1 0
13 43 2 0
17 44 1 6
15 45 1 1
11 46 1 0
46 47 1 0
46 48 2 0
2 49 1 0
6 50 1 0
M CHG 2 46 1 47 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 698.76Molecular Weight (Monoisotopic): 698.2869AlogP: 6.87#Rotatable Bonds: 10Polar Surface Area: 124.34Molecular Species: NEUTRALHBA: 10HBD: ┄#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): ┄#RO5 Violations (Lipinski): 3CX Acidic pKa: ┄CX Basic pKa: 7.88CX LogP: 6.85CX LogD: 6.25Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.08Np Likeness Score: -0.79
References 1. Chen ZS, Kawabe T, Ono M, Aoki S, Sumizawa T, Furukawa T, Uchiumi T, Wada M, Kuwano M, Akiyama SI.. (1999) Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter., 56 (1): [PMID:10570049 ] [10.1124/mol.56.6.1219 ] 2. Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD.. (2001) Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport., 61 (1): [PMID:11585759 ] 3. Sumizawa T, Chen ZS, Chuman Y, Seto K, Furukawa T, Haraguchi M, Tani A, Shudo N, Akiyama SI.. (1997) Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P., 51 (1): [PMID:9058594 ] 4. Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A.. (2000) Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P., 391 (1): [PMID:10729360 ] [10.1016/s0014-2999(00)00047-9 ] 5. Jedlitschky, G G and 5 more authors. 1997-10-01 ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. [PMID:9355767 ]